Macrophage-Derived tumor necrosis factor and Tumor-Derived of leukemia inhibitory factor and interleukin-6: Possible cellular mechanisms of cancer cachexia

Annals of Surgical Oncology

Volumn 3, Issue 1, 1996, Pages 29-35

  Billingsley, Kevin G ^a   Fraker, Douglas L ^a   Strassmann, Gideon ^b   Loeser, Caroline ^a   Fliot, Helen M ^c   Alexander, H Richard ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^c National Institutes of Health ^*

Author keywords

Cachexia; Cytokine; Interleukin 6; Leukemia inhibitory factor; Macrophage; Tumor necrosis factor

Indexed keywords

ANTIBODY; GROWTH INHIBITOR; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; LIF PROTEIN, MOUSE; LYMPHOKINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CACHEXIA; CELL CULTURE; COCULTURE; EXPERIMENTAL NEOPLASM; IMMUNOLOGY; METABOLISM; MOUSE; PATHOLOGY; UPREGULATION;

ANIMALS; ANTIBODIES; CACHEXIA; COCULTURE TECHNIQUES; GROWTH INHIBITORS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MICE; NEOPLASMS, EXPERIMENTAL; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0029686718     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02409048     Document Type: Article

References (17)

1. DeWys WD, Begg D, Lavin PT. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980;69:491-9.
2. Warren S. The immediate causes of death in the cancer. Am J Med Sci 1932;184:610-5.
3. Nixon DW, Heymsfield SB, Cohen AE, Kutner MH. Protein calorie undernutrition in hospitalized cancer patients. Am J Med 1980;68:683-90.
4. Langstein HN, Norton JA. Mechanisms of cancer cachexia. Hematol Oncol Clin North Am 1991;5:103-23.
5. McNamara MJ, Alexander HR, Norton JA. Cytokines and their role in the pathophysiology of cancer cachexia. JPEN 1992;16:505-35.
6. Stovroff MC, Fraker DL, Swedenborg JA, Norton JA. Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat. Cancer Res 1988;48:4567-72.
7. Darling G, Fraker DL, Jensen JC, Gorschboth CM, Norton JA. Cachectic effects of recombinant human tumor necrosis factor in rats. Cancer Res 1990;50:4008-13.
8. Balkwill F, Osborne R, Burke F, et al. Evidence for tumor necrosis factor/cachectin production in cancer. Lancet 1987; 2:1229-32.
9. Waring P, Wycherley K, Gary D, Nicola N, Metcalf D. Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J Clin Invest 1992;90: 2031-7.
10. Jablons DM, McIntosh JK, Mulé JJ. Induction of interferon-2/interleukin-6 by cytokine administration and detection of circulating interleukin-6 in the tumor bearing state. Ann N Y Acad Sci 1989;557:157-60.
11. Sherry BA, Gelin J, Fong Y, et al. Anticachectin/tumor necrosis factor-α antibodies attenuate development of cachexia in tumor models. FASEB J 1989;3:1956-62.
12. Matthys P, Heremans H, Opdenakker G, Billiau A. Anti-interferon-gamma antibody treatment, growth of Lewis lung tumors in mice and tumor-associated cachexia. Eur J Cancer 1991;27:182-7.
13. Langstein HN, Doherty GM, Fraker DL, Buresh CM, Norton JA. The roles of interferon-gamma and tumor necrosis factor in an experimental rat model of cancer cachexia. Cancer Res 1991;51:2302-6.
14. Strassmann G, Fong M, Kenney JS, Jacob CO. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 1992;89:1681-4.
15. Strassmann G, Masui Y, Chizzonite R, Fong M. Mechanisms of experimental cancer cachexia. J Immunol 1993;150: 2341-5.
16. Fraker DL, Langstein HN, Norton JA. Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity. J Exp Med 1989;170:1015-20.
17. Strassmann G, Jacob C, Evans R, Beell D, Fong M. Mechanisms of experimental cancer cachexia interaction between mononuclear phagocytes and colon 26 carcinoma and its relevance to IL-6 mediated cancer cachexia. J Immunol 1992; 148:3674-8.